- Resources
New Treatments In Multiple Sclerosis
British researchers have found that 71 percent of patients with relapsing-remitting multiple sclerosis (MS) who were treated with the experimental drug alemtuzumab in a recent study showed no disease activity after four years. This figure is twice the percentage of patients who achieve remission for this period of time who take the standard treatment Rebif, the scientists say.
Read moreMore information on "New Treatments In Multiple Sclerosis"
From Our Experts
An Introduction to Multiple Sclerosis
Multiple sclerosis (MS) is one of the most commonly diagnosed neurological disorders among young adults. Most people are diagnosed between... Read more »
Multiple Sclerosis Treatment: The Medical Marijuana Controversy
The list of multiple sclerosis symptoms is a lengthy and, at its worst, it can result in total disability. MS is also known to cause... Read more »
Making Multiple Sclerosis Treatment Developments Available to the...
The latest from Neurology on MS. Takin’ It to the Streets- by the Doobie Brothers/Michael McDonald You don’t know me but I'm your... Read more »
Multiple Sclerosis Treatment Developments
The World Congress on Treatment and Research in MS took place recently. At this important MS meeting there were scientific oral... Read more »
Lobbying for Reform: The High Cost of Multiple Sclerosis Treatment
Have you seen the new page at MultipleSclerosisCentral.com - Health Care and Insurance? If not, check it out. We’ve been having some... Read more »
From Our Sources
FDA Gives New Multiple Sclerosis Drug Priority Review Status
The U.S. Food and Drug Administration (FDA) has granted priority review status to an experimental multiple sclerosis (MS) drug called cladribine.... Read more »
Multiple Sclerosis (MS)
Source: Harvard Decision Guide
When To Call A Professional Call your doctor immediately if you have symptoms of multiple sclerosis. Prognosis A minority of those with multiple... Read more »
FDA approves Extavia for multiple sclerosis
The U.S. Food and Drug Administration has approved a new medication called Extavia for the treatment of multiple sclerosis (MS). Extavia is designed... Read more »
Marijuana-Based Multiple Sclerosis Drug Goes on Sale in the UK...
A new cannabis-based drug called Sativex has gone on sale in the United Kingdom as a treatment for multiple sclerosis (MS). Sativex is approved to... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
